Keywords: مهار کننده پروتئین بافتی; VTE; venous thromboembolism; HSCT; hematopoietic stem cell transplant; LMWH; low molecular weight heparin; IMIDs; immunomodulatory drugs; AML; acute myeloid leukemia; IQR; interquartile range; TAT; thrombin antithrombin; FVII; factor VII; FVIII; factor VI
مقالات ISI مهار کننده پروتئین بافتی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مهار کننده پروتئین بافتی; ADP; adenosine diphosphate; APC; activated protein C; AT-III; antithrombin III; ATP; adenosine triphosphate; cAMP; cyclic adenosine monophosphate; CLP; cecal ligation - perforation; DIC; disseminated intravascular coagulation; LPS; lipopolysaccharide; IL-
Keywords: مهار کننده پروتئین بافتی; aCL; anticardiolipin; ADP; adenosine diphosphate; APOH; apolipoprotein H; APS; antiphospholipid syndrome; β2GPI; β2-glycoprotein I; DVT; deep vein thrombosis; FDR; false discovery rate; GO; gene ontology; IL; interleukin; IRAK 1; interleukin-1 receptor-
Keywords: مهار کننده پروتئین بافتی; AASVV; ANCA associated small vessel vasculitis; APS; antiphospholipid antibody syndrome; CAD; coronary artery disease; cfDNA; cell-free deoxyribonucleic acid; citH3; citrullinated histone 3; CD; Crohn's disease; DPI; diphenylene iodonium; DNA; deoxyribonu
Keywords: مهار کننده پروتئین بافتی; A2Ms; α-2- macroglobulins; AFLEI; elastase inhibitor from Aspergillus flavus; AFUEI; elastase inhibitor from Aspergillus fumigatus; AP; α-2-antiplasmin; AT; antithrombin; bFGF; basic fibroblast growth factor; BSuPI; Bacillus subtilis protease inhibitor;
Keywords: مهار کننده پروتئین بافتی; Blood coagulation; Tissue factor; Thrombin; Platelets; Protease-activated receptors; Metastasis; AT; antithrombin; BMI; body mass index; CA-125; cancer antigen 125; CCC; clear cell carcinoma; CD; cluster of differentiation; CG; control group; DVT; deep ve
Keywords: مهار کننده پروتئین بافتی; aPTT; activated partial thromboplastin time; AT; antithrombin; CAT; calibrated automated thrombography; ETP; endogenous thrombin potential; F1Â +Â 2; prothrombin fragments F1Â +Â 2; FII; prothrombin; FVIII:C; factor VIII coagulant activity; IDDM; insulin-
Keywords: مهار کننده پروتئین بافتی; Hemostasis; Fucoidan; Hemophilia; NMR; Structure; Screening; NASP; non-anticoagulant sulfated polysaccharide; TFPI; tissue factor pathway inhibitor; TF; tissue factor; s.c.; subcutaneous; p.o.; per os (oral); Mw; molecular weight; polyD; polydispersity; O
Keywords: مهار کننده پروتئین بافتی; PUC; Premature uterine contractions; PPROM; Preterm premature rupture of membranes; PTL; Preterm labor; aPTT; Activated partial thromboplastin time; PT; Prothrombin time; PT F1Â +Â 2; Prothrombin Fragments F1Â +Â 2; TAT; Thrombin anti thrombin; PAI 1; Pla
Keywords: مهار کننده پروتئین بافتی; OC; Oral contraceptives; DRSP-OC; drospirenone-containing oral contraceptives; APC; activated protein C; TFPI; tissue factor pathway inhibitor; SHBG; sex-hormone-binding globulin; ETP-APC and ETP+Â APC respectively; the endogenous thrombin potential in th
Keywords: مهار کننده پروتئین بافتی; CPB; cardiopulmonary bypass; TG; thrombin generation; CAT; calibrated automated thrombography; TFPI; tissue factor pathway inhibitor; AT; antithrombin; CABG; coronary artery bypass grafting; ACT; activated clotting time; UFH; unfractionated heparin; PPP;
Keywords: مهار کننده پروتئین بافتی; Orange juice; Tissue factor; Tissue factor pathway inhibitor; Procoagulant activity;
Keywords: مهار کننده پروتئین بافتی; AT; antithrombin; AZ; AstraZeneca; CAT; calibrated automated thrombogram; ETP; endogenous thrombin potential; LT; lag time; HTS; high-throughput screening; PPP; platelet poor plasma; PRP; platelet rich plasma; RU; resonance units; SPR; surface plasmon res
Anti-haemostatic compounds from the vampire snail Cumia reticulata: Molecular cloning and in-silico structure-function analysis
Keywords: مهار کننده پروتئین بافتی; NGS; Next generation sequencing; RNA-Seq; RNA sequencing; ShKT; ShK toxin; SmCI; Sabellastarte magnifica Carboxypeptidase inhibitor; TFPI; tissue factor pathway inhibitor; vWFA; Von Willebrand factor A domain; Mollusc; Anti-haemostatic compounds; Protein
Comparative Effectiveness of Enoxaparin vs Dalteparin for Thromboprophylaxis After Traumatic Injury
Keywords: مهار کننده پروتئین بافتی; comparative effectiveness; dalteparin; enoxaparin; prophylaxis; trauma; VTE; DID; difference-in-differences; LMWH; low-molecular-weight heparin; PE; pulmonary embolism; PTSF; Pennsylvania Trauma System Foundation; RR; rate ratio; SDF; standardized differe
Association of genetic polymorphisms with plasma TFPI level: Boon or curse for DVT patients - Study from India
Keywords: مهار کننده پروتئین بافتی; Deep vein thrombosis; Tissue factor pathway inhibitor; Polymorphisms;
Full Length ArticleIncreased expression of TFPI in human carotid stenosis
Keywords: مهار کننده پروتئین بافتی; Atherothrombosis; Tissue factor pathway inhibitor; Carotid plaque; Anticoagulation; Vascular biology;
Tissue factor pathway inhibitor attenuates ER stress-induced inflammation in human M2-polarized macrophages
Keywords: مهار کننده پروتئین بافتی; TFPI; Cholesterol crystals; ER stress; Macrophages; Carotid endarterectomies; Inflammation; CC; cholesterol crystals; CHOP; CCAAT/enhancer-binding protein homologous protein; ER; endoplasmic reticulum; MDMs; monocyte-derived macrophages; PBA; 4-phenylbuty
Regular articleOestrogen induced downregulation of TFPI expression is mediated by ERα
Keywords: مهار کننده پروتئین بافتی; ERα/β; Oestrogen rceptor alpha/beta; TFPI; Tissue factor pathway inhibitor; TF; tissue factor; E2; 17-β-oestradiol; EE2; 17-β-ethinyloestradiol; FUL; fulvestrant; CHX; cycloheximide; ERE; oestrogen response element; HRT; hormone replacement therapy; P
New observations on procoagulant properties of amniotic fluid: Microparticles (MPs) and tissue factor-bearing MPs (MPs-TF), comparison with maternal blood plasma
Keywords: مهار کننده پروتئین بافتی; MPs; microparticles; AF; amniotic fluid; TF; tissue factor; MPs-TF; tissue factor bearing MPs; TFPI; tissue factor pathway inhibitor; PS; phosphatidylserine; Microparticles; Amniotic fluid; Tissue factor; Tissue factor pathway inhibitor;
Maternal familial hypercholesterolaemia (FH) confers altered haemostatic profile in offspring with and without FH
Keywords: مهار کننده پروتئین بافتی; Apo; apolipoprotein; BMI; body mass index; CV; coefficient of variation; CVD; cardiovascular disease; ELISA; enzyme-linked immunosorbant assay; F1Â +Â 2; protrombin fragment 1Â +Â 2; FH; familial hypercholesterolaemia; LDL; low density lipoprotein; PAI-1;
The anticoagulant therapy for sepsis-associated disseminated intravascular coagulation
Keywords: مهار کننده پروتئین بافتی; Disseminated intravascular coagulation (DIC); Antithrombin; Thrombomodulin; Activated Protein C; Tissue factor pathway inhibitor; Japanese Association for Acute Medicine (JAAM);
The effect of tissue factor pathway inhibitor on the expression of monocyte chemotactic protein-3 and IκB-α stimulated by tumour necrosis factor-α in cultured vascular smooth muscle cells
Keywords: مهار کننده پروتئین بافتی; Gene therapy; IκB-α; Monocyte chemotactic protein-3; Tissue factor pathway inhibitor; Vascular smooth muscle cellsThérapie génique; IkB-α; Protéine 3 chimiotactique monocytaire; Inhibiteur de la voie du facteur tissulaire; Cellule musculaire lisse vascula
Screening and surveillance for colorectal cancer: state of the art
Keywords: مهار کننده پروتئین بافتی; ACRIN; American College of Radiology Imaging Network; ADR; adenoma detection rate; BMP3; bone morphogenetic protein 3; CI; confidence interval; CMS; Centers for Medicare and Medicaid Services; CRC; colorectal cancer; CTC; CT colonography; DCBE; double-con
Protein Z/protein Z-dependent protease inhibitor system in human non-small-cell lung cancer tissue
Keywords: مهار کننده پروتئین بافتی; ABC; avidin - biotin complex technique; antibody T2G1; antibody directed to fibrin II (des fibrinopeptide B fibrin); antibody 1-8C6; antibody which reacts with fibrinogen or des fibrinopeptide A fibrin but not with des fibrinopeptide B fibrin; AT; antit
A hypercoagulable and hypofibrinolytic state is detectable by global methods in patients with retinal vein occlusion
Keywords: مهار کننده پروتئین بافتی; Clot lysis time; Endogenous thrombin potential; Retinal vein occlusion; Tissue factor pathway inhibitor;
Increased heparanase level and procoagulant activity in orthopedic surgery patients receiving prophylactic dose of enoxaparin
Keywords: مهار کننده پروتئین بافتی; DVT; deep vein thrombosis; HS; heparan sulfate; TF; tissue factor; TFPI; tissue factor pathway inhibitor; PE; pulmonary emboli; TAT; thrombin-antithrombin; PAI; plasminogen activator inhibitor; LMWH; low molecular weight heparin; TPA; tissue plasminogen a
Assembly of the prothrombinase complex on the surface of human foreskin fibroblasts: Implications for connective tissue growth factor
Keywords: مهار کننده پروتئین بافتی; FXa; activated factor X; CTGF/CCN2; connective tissue growth factor; TF; tissue factor; TSP1; thrombospondin-1; HFF; human foreskin fibroblasts; FVII; factor VII; FX; factor X; FV; factor V; II; prothrombin; TGFβ; transforming growth factor beta; TGFβRI
Global haemostasis assays, from bench to bedside
Keywords: مهار کننده پروتئین بافتی; α; angle that assesses rate of clot formation; α2M; α2-macroglobulin; AMC; 7-amino-4-methylcoumarine; AT; antithrombin; AUC; area under the curve; APC; activated protein C; aPTT; activated partial thromboplastin time; A10; the amplitude after ten minut
Endogenous Anticoagulants
Keywords: مهار کننده پروتئین بافتی; antithrombin; coagulation; protein C; protein S; tissue factor pathway inhibitor
Increased tissue factor pathway inhibitor and homocysteine in Alzheimer's disease
Keywords: مهار کننده پروتئین بافتی; Alzheimer's disease; Endothelial injury; Homocysteine; Tissue factor pathway inhibitor;
Adenovirus-mediated tissue factor pathway inhibitor gene transfer induces apoptosis by blocking the phosphorylation of JAK-2/STAT-3 pathway in vascular smooth muscle cells
Keywords: مهار کننده پروتئین بافتی; Tissue factor pathway inhibitor; Vascular smooth muscle cell; Apoptosis; Restenosis; JAK-2/STAT-3; Survivin;
Microparticles (MPs), tissue factor (TF) and tissue factor inhibitor (TFPI) in cord blood plasma. A preliminary study and literature survey of procoagulant properties of MPs
Keywords: مهار کننده پروتئین بافتی; Microparticles; Tissue factor; Tissue factor pathway inhibitor; Cord blood
An assay to evaluate heparanase procoagulant activity
Keywords: مهار کننده پروتئین بافتی; TF; tissue factor; TFPI; tissue factor pathway inhibitor; HS; heparan sulfate; CS; cesarean section; IUGR; intrauterine growth restriction; PGE2; prostaglandin E2; Heparanase; Tissue factor; Coagulation; Pregnancy;
Heparin affinity of factor VIIa: Implications on the physiological inhibition by antithrombin and clearance of recombinant factor VIIa
Keywords: مهار کننده پروتئین بافتی; FVIIa; Factor VIIa; TF; Tissue Factor; rFVIIa; recombinant FVIIa; LMWH; Low molecular weight heparin; UHF; Unfractionated heparin; SPR; Surface Plasmon resonance; TFPI; Tissue factor pathway inhibitor; RU; Response units;
The relationship between plasma and placental tissue factor, and tissue factor pathway inhibitors in severe pre-eclampsia patients
Keywords: مهار کننده پروتئین بافتی; Pre-eclampsia; Tissue factor; Tissue factor pathway inhibitor; Pathological hypercoagulable state;
Murine strain differences in hemostasis and thrombosis and tissue factor pathway inhibitor
Keywords: مهار کننده پروتئین بافتی; Mouse; Strain; Hemostasis; Thrombosis; Tissue factor; Tissue factor pathway inhibitor
Coagulation-Fibrinolysis Changes During Off-Pump Bypass: Effect of Two Heparin Doses
Keywords: مهار کننده پروتئین بافتی; ACT; activated clotting time; CABG; coronary artery bypass graft surgery; CPB; cardiopulmonary bypass; F1+2; prothrombin fragment 1+2; OPCABG; off-pump coronary artery bypass graft surgery; PAP; plasmin-antiplasmin complex; PFA; platelet function analyzer
Plasma factor and inhibitor composition contributes to thrombin generation dynamics in patients with acute or previous cerebrovascular events
Keywords: مهار کننده پروتئین بافتی; AT; antithrombin; AUC; area under the curve; CRP; C-reactive protein; CT; computed tomography; F; factor; IL-6; interleukin-6; LDL; low density lipoprotein; MaxL; maximum level of thrombin production; MaxR; maximum level of thrombin production; MRI; magne
HVJ-AVE liposome-mediated Tissue Factor Pathway Inhibitor (TFPI) gene transfer with recombinant TFPI (rTFPI) irrigation attenuates restenosis in atherosclerotic arteries
Keywords: مهار کننده پروتئین بافتی; Angioplasty; Atherosclerosis; Gene therapy; Tissue Factor Pathway Inhibitor; Recombinant TFPI protein; Restenosis;
Porphyromonas gingivalis infection and prothrombotic effects in human aortic smooth muscle cells
Keywords: مهار کننده پروتئین بافتی; VSMC; vascular smooth muscle cells; HAEC; human aortic endothelial cells; HASMC; human aortic smooth muscle cells; TF; tissue factor; TFPI; tissue factor pathway inhibitor; LPS; lipopolysacharide; LDH; lactate dehydrogenase; Infection; Periodontitis; P. g
Expression of the V264M TFPI mutant in endothelial cell cultures may involve mRNA stability
Keywords: مهار کننده پروتئین بافتی; TF; tissue factor; TFPI; tissue factor pathway inhibitor; CAT; chloramphenicol acetyltransferase; HCAEC; human coronary artery endothelial cells.; Endothelial cells; Expression; mRNA; Stability; Mutant; TFPI;
Tissue factor pathway inhibitor, vascular risk factors and subclinical atherosclerosis: The Multi-Ethnic Study of Atherosclerosis
Keywords: مهار کننده پروتئین بافتی; Atherosclerosis; Coronary heart disease; Tissue factor pathway inhibitor; Risk factor;
Berberine, a natural lipid-lowering drug, exerts prothrombotic effects on vascular cells
Keywords: مهار کننده پروتئین بافتی; Berberine; Tissue factor; Tissue factor pathway inhibitor; mRNA Stability; Simvastatin
Heparanase coagulation and cancer progression
Keywords: مهار کننده پروتئین بافتی; heparanase; tissue factor; tissue factor pathway inhibitor; cancer
Tissue Factor Pathway Inhibitor [Tfpi]: A Natural Coagulation Inhibitor and Potential Therapeutic Agent – A Review
Keywords: مهار کننده پروتئین بافتی; Coagulation pathways; Tissue factor pathway inhibitor; Tissue factor
Changes in tissue factor and the effects of tissue factor pathway inhibitor on transient focal cerebral ischemia in rats
Keywords: مهار کننده پروتئین بافتی; Tissue factor; Focal cerebral ischemia; Reperfusion injury; Tissue factor pathway inhibitor; Cerebral microcirculation
Platelet aggregation and thrombosis in xenotransplantation between pigs and humans
Keywords: مهار کننده پروتئین بافتی; HXR; hyperacute rejection; DXR; delayed xenograft rejection; TFPI; tissue factor pathway inhibitor; fgl2; fibrinogen-like protein 2; vWF; von Willebrand factor; IC; immune complexes; PBMC; peripheral blood mononuclear cell; PBPC; peripheral blood progenit
Dyslipidemia shifts the tissue factor/tissue factor pathway inhibitor balance toward increased thrombogenicity in atherosclerotic plaques: Evidence for a corrective effect of statins
Keywords: مهار کننده پروتئین بافتی; Tissue factor; Tissue factor pathway inhibitor; Atherosclerosis; Statin
Tissue factor and tissue factor pathway inhibitor: A potential role in pregnancy and obstetric vascular complications?
Keywords: مهار کننده پروتئین بافتی; Tissue factor; Tissue factor pathway inhibitor; Pregnancy; Gestational vascular complications